ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO105

A Mouse Model of Moderate Diabetic Nephropathy on a Metabolic Syndrome Background

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • van Koppen, Arianne, TNO, Leiden, Netherlands
  • De Ruiter, Christa, TNO, Leiden, Netherlands
  • Attema, Joline, TNO, Leiden, Netherlands
  • Stokman, Geurt, TNO, Leiden, Netherlands
  • Stoop, Reinout, TNO, Leiden, Netherlands
Background

Mouse models of diabetic nephropathy (DN) which not only recapitulate the early phases of the disease but also progress to a more advanced phase are urgently needed. We aim to develop a translational DN mouse model on metabolic syndrome background by incorporating the three main features of DN viz hyperglycemia, hyperlipidemia and hypertension.

Methods

Male KKAy mice were uninefrectomized and received high fat (45%) diet alone (HFD) or with prohypertensive (HFD+hyp) for 14 wk. At regular intervals, systolic blood pressure (SBP), 24h diuresis and plasma was collected. At sacrifice, GFR (inulin clearance) was determined, and renal injury was scored using histology. Age-matched chow-fed animals were controls.

Results

Mice fed with HFD developed hyperglycemia and hyperlipidemia. The prohypertensive group developed hypertension. GFR was significantly reduced in the HFD+hyp group compared to controls (2.5µl/min/g BW vs 4.6µl/min/g BW). Renal injury score showed glomerular hypertrophy, mesangium expansion, glomerulosclerosis, hyalinosis, micro-aneurisms and tubulo-interstitial fibrosis.

Conclusion

Combining three key features of DN in one mouse model induces moderate DN with a decline in GFR and morphological features resembling the human situation. We are currently forming a consortium to identify the temporal dynamics of key processes involved in disease development and progression.

Funding

  • Government Support - Non-U.S.